Literature DB >> 25858892

Regression of an HCV-associated disseminated marginal zone lymphoma under IFN-free antiviral treatment.

Philippe Sultanik1, Caroline Klotz2, Philippe Brault3, Stanislas Pol1, Vincent Mallet1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25858892     DOI: 10.1182/blood-2014-12-618652

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  17 in total

1.  Impact of DAA-Based Regimens on HCV-Related Extra-Hepatic Damage: A Narrative Review.

Authors:  Evangelista Sagnelli; Caterina Sagnelli; Antonio Russo; Mariantonietta Pisaturo; Clarissa Camaioni; Roberta Astorri; Nicola Coppola
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

2.  Clinicopathologic characteristics and outcomes of transformed diffuse large B-cell lymphoma in hepatitis C virus-infected patients.

Authors:  Jeff Hosry; Roberto N Miranda; Felipe Samaniego; Minas P Economides; Harrys A Torres
Journal:  Int J Cancer       Date:  2017-11-03       Impact factor: 7.396

Review 3.  The oncologic burden of hepatitis C virus infection: A clinical perspective.

Authors:  Harrys A Torres; Terri Lynn Shigle; Nassim Hammoudi; James T Link; Felipe Samaniego; Ahmed Kaseb; Vincent Mallet
Journal:  CA Cancer J Clin       Date:  2017-07-06       Impact factor: 508.702

Review 4.  Extrahepatic manifestations of hepatitis C infection: navigating CHASM.

Authors:  Amy C Sherman; Kenneth E Sherman
Journal:  Curr HIV/AIDS Rep       Date:  2015-09       Impact factor: 5.071

Review 5.  Extrahepatic cancers and chronic HCV infection.

Authors:  Stanislas Pol; Anaïs Vallet-Pichard; Olivier Hermine
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2018-01-17       Impact factor: 46.802

Review 6.  Hepatitis C Associated B-cell Non-Hodgkin Lymphoma: Clinical Features and the Role of Antiviral Therapy.

Authors:  Syed Tasleem; Gagan K Sood
Journal:  J Clin Transl Hepatol       Date:  2015-06-15

Review 7.  Infectious Aetiology of Marginal Zone Lymphoma and Role of Anti-Infective Therapy.

Authors:  Salvatore Perrone; Gianna Maria D'Elia; Giorgia Annechini; Alessandro Pulsoni
Journal:  Mediterr J Hematol Infect Dis       Date:  2016-01-01       Impact factor: 2.576

Review 8.  Antiviral therapy of hepatitis C as curative treatment of indolent B-cell lymphoma.

Authors:  Michele Merli; Giuseppe Carli; Luca Arcaini; Carlo Visco
Journal:  World J Gastroenterol       Date:  2016-10-14       Impact factor: 5.742

9.  Hepatitis C and double-hit B cell lymphoma successfully treated by antiviral therapy.

Authors:  Giovanni Galati; Lorenzo Rampa; Umberto Vespasiani-Gentilucci; Mirella Marino; Francesco Pisani; Carlo Cota; Alessandro Guidi; Antonio Picardi
Journal:  World J Hepatol       Date:  2016-10-18

Review 10.  Systemic manifestations of hepatitis C infection.

Authors:  Lydia Tang; Lauren Marcell; Shyam Kottilil
Journal:  Infect Agent Cancer       Date:  2016-05-23       Impact factor: 2.965

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.